Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-treated Pts With Metastatic Esophageal Cancer.

NCT00209716 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer

Interventions

DRUG: Taxotere
DRUG: 5-Fluorouracil
DRUG: Briplatin

Sponsor

Hokkaido Gastrointestinal Cancer Study Group

Collaborators

[object Object]